Status:

RECRUITING

Case-Finding for Neurocognitive Disorders in Pavia

Lead Sponsor:

IRCCS National Neurological Institute "C. Mondino" Foundation

Conditions:

Dementia

Mild Cognitive Impairment

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Dementia is a global public health challenge with a heavy caregiving burden, impacting families, communities, and healthcare systems. It is a priority in healthcare planning, with focus on early diagn...

Detailed Description

Dementia is currently one of the most urgent challenges that global public health must address, with a significant caregiving burden that deeply impacts families, communities, and healthcare systems. ...

Eligibility Criteria

Inclusion

  • For the Primary Outcome the inclusion criteria are:
  • Age 50 or older
  • Assessment conducted using GPcog/ACE-III depending on the setting
  • No prior diagnosis of cognitive decline
  • Ability to understand the study objectives and sign an informed consent
  • For the Primary Outcome the exclusion criteria are:
  • Age under 50
  • Presence of a diagnosis of cognitive decline
  • Limited knowledge of the Italian language
  • For the secondary outcome the inclusion criteria are:
  • Patient:
  • All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina;
  • Ability to understand the aims of the study and to sign an informed consent
  • Caregiver:
  • Age equal to or greater than 18 years
  • Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD;
  • Acceptance of informed consent and voluntary participation in the study.
  • Healthcare professionals:
  • All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training;
  • Acceptance of informed consent and voluntary participation in the study.
  • Fo the Secondary Outcome the exclusion criteria are:
  • Patient:
  • \- Inability to understand the aims of the study and to sign an informed consent
  • Caregiver:
  • Age under 18
  • Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee;
  • Caregivers with limited knowledge of the Italian language.

Exclusion

    Key Trial Info

    Start Date :

    July 11 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 31 2026

    Estimated Enrollment :

    490 Patients enrolled

    Trial Details

    Trial ID

    NCT06983119

    Start Date

    July 11 2024

    End Date

    July 31 2026

    Last Update

    May 21 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS National Neurological Institute "C. Mondino" Foundation

    Pavia, Pavia, Italy, 27100